In this context, the hypothesis emerges that rosavin may influence BMP-2 expression in human osteoblasts (HOBs), thereby opening new therapeutic possibilities for the treatment of osteoporosis and other metabolic bone diseases [14,15,16]. This evidence concerns the gene BMP2 and osteoporosis.